Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Scinai Immunotherapeutics Ltd SCNI

Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various... see more

Bullboard (NDAQ:SCNI)

View:
Post by whytestockson Sep 16, 2024 7:17pm

InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ:

BREAKING NEWS: $SCNI InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Schedules Virtual Panel Discussion on Plaque Psoriasis, Its Promising Novel SolutionScinai Immunotherapeutics ...more  
Post by whytestockson Aug 21, 2024 8:00pm

InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NA

BREAKING NEWS: $SCNI InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), EIB Close on Loan Restructuring AgreementScinai Immunotherapeutics (NASDAQ: SCNI) , a ...more  
Post by whytestockson Aug 20, 2024 11:02am

Scinai Announces Entering into $2 Million Private Equity Com

News; $SCNI Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing ShareholderScinai Announces Entering into $2 Million Private Equity Commitment ...more  
Post by whytestockson Aug 15, 2024 9:02pm

InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ:

BREAKING NEWS: $SCNI InvestorNewsBreaks - Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Reports Q2 2024 Financial Results, Shares Business UpdateScinai Immunotherapeutics (NASDAQ: SCNI) is a ...more  
Post by Iseneschalon Jun 17, 2024 9:30am

SCNI....DEBT to Equity conversion..... Sheesh

You will all get screwed.....go ahead and be a CHaser !!!! Now at $6.20.....watch out !!!!!!!!!!!!!!!!!!!!!!!!
Post by whytestockson Jun 07, 2024 5:30pm

NIH Researchers Unveil AI Tool to Predict Oncology Patients'

NEWS: $SCNI NIH Researchers Unveil AI Tool to Predict Oncology Patients' Response to ImmunotherapyScientists at the National Institutes of Health have designed an artificial intelligence (AI) tool ...more  
Post by Iseneschalon Jun 05, 2023 3:45pm

BVXV....Now if I was a gambling man....

I'd buy this L.O.D.....because theres a gap just over $1.69 that should get filled before the close which is in 15 minutes Me ...no position !
Post by Iseneschalon Jun 05, 2023 11:38am

BVXV....Phew.....call me lucky ; )

Dodged a bullet there But I've re-loaded.....fingers crossed  What a game
Post by Iseneschalon Jun 05, 2023 11:33am

BVXV.....sold into that pop

I just take what the market gives I like leaving some for the next guy.....seriously.....this could easily pop Remember my target ; )
Post by Iseneschalon Jun 05, 2023 11:23am

BVXV.....whoa....this might not be done.....this needs some

volume Right at a crucial pivot that I previously mentioned $3.50 target .... Cheers !
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities